PDG62 CURRENT TREATMENT STATUS WITH PROPROTEIN CONVERTASE SUBTILISIN-KEXIN TYPE 9 INHIBITORS IN PATIENTS BASED ON A REAL-WORLD DATA ANALYSIS IN USA
May 1, 2019, 00:00
10.1016/j.jval.2019.04.741
https://www.valueinhealthjournal.com/article/S1098-3015(19)30933-7/fulltext
Title :
PDG62 CURRENT TREATMENT STATUS WITH PROPROTEIN CONVERTASE SUBTILISIN-KEXIN TYPE 9 INHIBITORS IN PATIENTS BASED ON A REAL-WORLD DATA ANALYSIS IN USA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30933-7&doi=10.1016/j.jval.2019.04.741
First page :
Section Title :
Open access? :
No
Section Order :
10334